Advertisement
Research Article| Volume 25, ISSUE 6, P1458-1466, June 2016

Pre-hospital Delay as Determinant of Ischemic Stroke Outcome in an Italian Cohort of Patients Not Receiving Thrombolysis

      Background

      Pre-hospital delay in acute stroke is critical to the administration of thrombolysis and affects patients' clinical outcome. In this study, the impact of pre-hospital delay on the outcome of ischemic stroke was investigated in an Italian cohort of patients who did not receive thrombolysis.

      Methods

      Data from a cohort of 1847 patients, suffering from first-ever ischemic stroke and referred to an in-hospital clinical pathway were analyzed retrospectively. The relationship between pre-hospital delay and 1-month mortality was assessed with adjustment for demographics, premorbid disability, and stroke severity, which was graded according to the Scandinavian Stroke Scale, with higher scores indicating less severity.

      Results

      Five hundred and twelve patients (27.7%) arrived at hospital within 2 hours of symptom onset. A significant correlation was found between early arrival and a reduced risk of 1-month mortality (hazard ratio .65; 95% confidence interval .48-.89; P = .02). There was a significant interaction (P = .01) between pre-hospital delay and the neurological score on mortality in the multivariate model, and the survival advantage of early admission was significant only for patients with scores on the Scandinavian Stroke Scale less than 18 (hazard ratio .54; 95% confidence interval .34-.85; P = .008).

      Conclusions

      Our study suggests that reducing pre-hospital delay can increase the probability of survival in patients with ischemic stroke, especially those who are most severely affected. Even if the patients cannot benefit from thrombolysis, survival rates can be increased provided that they are managed according to standardized care processes.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wardlaw J.M.
        • Murray V.
        • Berge E.
        • et al.
        Thrombolysis for acute ischaemic stroke.
        Cochrane Database Syst Rev. 2009; (CD000213)
        • Lees K.R.
        • Bluhmki E.
        • von Kummer R.
        • et al.
        Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
        Lancet. 2010; 375: 1695-1703
        • Saver J.L.
        • Levine S.R.
        Alteplase for ischaemic stroke—much sooner is much better.
        Lancet. 2010; 375: 1667-1668
        • Qureshi A.I.
        • Kirmani J.F.
        • Sayed M.A.
        • et al.
        Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
        Neurology. 2005; 64: 2115-2120
        • Naganuma M.
        • Toyoda K.
        • Nonogi H.
        • et al.
        Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study.
        Cerebrovasc Dis. 2009; 28: 33-38
        • Every N.R.
        • Hochman J.
        • Becker R.
        • et al.
        Critical pathways: a review.
        Circulation. 2000; 101: 461-465
        • Kwan J.
        • Sandercock P.
        In-hospital care pathways for stroke.
        Cochrane Database Syst Rev. 2004; (CD002924)
      1. Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke.
        Stroke. 2000; 31: 1002-1012
        • Adams H.P.
        • Del Zoppo G.
        • Alberts M.J.
        • et al.
        Guidelines for the early management of adults with ischemic stroke.
        Stroke. 2007; 38: 1655-1711
        • Stroke prevention and educational awareness diffusion (SPREAD)
        VII Edizione. Ictus cerebrale: linee guida italiane di prevenzione e trattamento.
        • Denti L.
        • Scoditti U.
        • Tonelli C.
        • et al.
        The poor outcome of ischemic stroke in very old people: a cohort study of its determinants.
        J Am Ger Soc. 2010; 58: 12-17
        • Van Swieten J.C.
        • Koudstaal P.J.
        • Visser M.C.
        • et al.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1988; 19: 604-607
        • Jennet B.
        • Bond M.
        Assessment of outcome after severe brain damage: a practical scale.
        Lancet. 1975; 1: 480-484
        • Scandinavian Stroke Study Group
        Multicenter trial of hemodilution in ischaemic stroke—background and study protocol.
        Stroke. 1985; 16: 885-890
        • Bamford J.
        • Sandercock P.
        • Dennis M.
        • et al.
        Classification and natural history of clinically identifiable subtypes of cerebral infarction.
        Lancet. 1991; 337: 1521-1526
        • Adams Jr, H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        Classification of subtypes of acute ischemic stroke: definition for use in a multicenter clinical trial: TOAST. Trial of Org 10 172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Hacke W.
        • Kaste M.
        • Bluhmki E.
        • et al.
        Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
        N Engl J Med. 2008; 359: 1317-1329
        • Kaste M.
        Stroke: advances in thrombolysis.
        Lancet Neurol. 2013; 12: 2-4
        • Emberson J.
        • Lees K.R.
        • Lyden P.
        • et al.
        Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomized trials.
        Lancet. 2014; 84: 1929-1935
        • Bath P.M.
        • Gray L.J.
        • et al.
        • Optimising Analysis of Stroke Trials (OAST) Collaboration
        Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials.
        Stroke. 2007; 38: 1911-1915
        • Ovbiagele B.
        • Lyden P.D.
        • Saver J.L.
        • et al.
        Disability status at 1 month is a reliable proxy for final ischemic stroke outcome.
        Neurology. 2012; 75: 688-692